In This Section
You searched for:
Evaluation and Management of Connective Tissue Disease-Associated Interstitial Lung Disease
Course ID: 2928
There are complex interactions between connective tissue disease (CTD) and interstitial lung disease (ILD), particularly in the PH patient. Clinicians that care for these patients will benefit from a deeper understanding of CTD and the ILD aspects of this diverse spectrum of disease. There are many clinical dilemmas to address and this course will focus on an approach to the evaluation and management of CTD-associated ILD.
Interstitial Lung Disease in Systemic Sclerosis
Course ID: 2927
Interstitial Lung Disease (ILD) is an important cause of morbidity and mortality in scleroderma patients. This presentation will discuss the clinical evaluation, diagnosis and management of scleroderma interstitial lung disease (SSc-ILD). It will cover the pathogenesis of scleroderma, new treatment targets and current clinical trials in SSc-ILD. Clinical cases will be used to illustrate key points in the evaluation and management of SSc-ILD.
PH Group III: Cases and Challenges
Course ID: 2819
This session will provide a case-centered update on pathogenesis and epidemiology and significance of pulmonary hypertension in parenchymal lung disease. The currently available treatment data and ongoing clinical trials will be discussed.